Wellness Robots and the Path to Full Autonomy
Overview
This paper defines autonomous wellness robots using a six-level Care Robot Autonomy Scale (CRAS) modeled on SAE J3016. It presents Ryan, developed at the University of Denver and commercialized by DreamFace Technologies, as a case study. NIH/NIA-funded data (N=18; 887 hours) reports statistically significant cognitive improvement (SLUMS +2.61, p = 0.015) and a trend toward reduced depressive symptoms (PHQ-9 -2.50, p = 0.073).
Generated from attributed reports · Updated 53 minutes ago
Event evidence and corrections
0 attributed source owners. Ownership does not establish independent confirmation. Quantities are reported separately and are never added together.
Reported quantity · Reported duration: 887 hours · Basis not reported
“across four wellness-aligned dimensions. We present Ryan, developed initially at the University of Denver and commercialized by DreamFace Technologies, as a case study. NIH/NIA-funded longitudinal evidence (N = 18; 887 hours) shows statistically significant cognitive improvement (SLUMS +2.61, p = 0.015) and a clinically meaningful directional reduction in depressive symptoms (PHQ-9 -2.50, p = 0.073), with no novelty”
Exact source · revision 1Source owner not reported
Report timeline
Follow attributed reports and material updates.
- arXiv Robotics — research abstractsSignalWellness Robots and the Path to Full Autonomy
This paper defines autonomous wellness robots using a six-level Care Robot Autonomy Scale (CRAS) modeled on SAE J3016. It presents Ryan, developed at the University of Denver and commercialized by DreamFace Technologies, as a case study. NIH/NIA-funded data (N=18; 887 hours) reports statistically significant cognitive improvement (SLUMS +2.61, p = 0.015) and a trend toward reduced depressive symptoms (PHQ-9 -2.50, p = 0.073).
Event coverage history
There is not enough continuous observation data to show a trend.
Timezone · UTC
Article dates follow your selected timezone. Briefing editions use Hong Kong time (UTC+8).